Binding of isofraxidin to bovine serum albumin
✍ Scribed by Jiaqin Liu; Jianniao Tian; Zhide Hu; Xingguo Chen
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2004
- Tongue
- English
- Weight
- 110 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The binding of isofraxidin to bovine serum albumin (BSA) was studied under physiological conditions with BSA concentration of 1.5×10^−6^ mol · L^−1^ and drug concentration in the range of 1.67×10^−6^ mol · L^−1^ to 2.0×10^−5^ mol · L^−1^. Fluorescence quenching spectra in combination with uv absorption spectroscopy, Fourier transform infrared (FTIR) spectroscopy, and CD spectroscopy was used to determine the drug‐binding mode, binding constant, and the protein structure changes in the presence of isofraxidin in aqueous solution. The linearity of Scatchard plot indicates that isofraxidin binds to a single class of binding sites on BSA and the values given for the binding constants agree very closely with those obtained by the modified Stern‐Volmer equation. The thermodynamic parameters, enthalpy change (Δ__H__) and entropy change (Δ__S__), were calculated to be −17.63 kJ · mol^−1^ and 51.38 J · mol^−1^ · K^−1^ according to the van't Hoff equation, which indicated that hydrophobic interaction played a main role in the binding of isofraxidin to BSA. © 2004 Wiley Periodicals, Inc. Biopolymers, 2004
📜 SIMILAR VOLUMES
## Abstract The interaction between bovine serum albumin (BSA) and tinidazole (__Tindamax__^®^; **1**) in aqueous solution was investigated in detail by means of UV/VIS and fluorescence spectroscopy, as well as through resonance light‐scattering (RLS) spectroscopy. The apparent binding constant and
The binding properties of hypoglycaemic drugs to glycosylated human serum albumin (G-HSA) were investigated using a ¯uorescence quenching method. Displacement patterns between tolbutamide and Sudlow's-site-speci®c drugs to G-HSA were also investigated. The order of the binding anities of these drug